Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening
about
Software and resources for computational medicinal chemistrySmall-molecule Bax agonists for cancer therapy.A 635-nm light-emitting diode (LED) therapy inhibits bone resorptive osteoclast formation by regulating the actin cytoskeleton.Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.Bis-enoxacin blocks rat alveolar bone resorption from experimental periodontitis.Enoxacin directly inhibits osteoclastogenesis without inducing apoptosisPeriodontitis in rats induces systemic oxidative stress that is controlled by bone-targeted antiresorptivesRational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.Covalent Immobilization of Enoxacin onto Titanium Implant Surfaces for Inhibiting Multiple Bacterial Species Infection and In Vivo Methicillin-Resistant Staphylococcus aureus Infection Prophylaxis.Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.Characterization of Regulatory Extracellular Vesicles from Osteoclasts.Bis-enoxacin inhibits bone resorption and orthodontic tooth movementThe Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM).Small molecules for bone diseases.Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesisVacuolar H+-ATPase: An Essential Multitasking Enzyme in Physiology and Pathophysiology
P2860
Q28728561-ABC4FFAD-78BB-48FD-B515-207CE4398442Q34231198-39812E9F-5302-4417-9CE5-5AD1065F91C9Q34787185-31876421-5BFE-47B4-80BF-E45E52CF9BE1Q34793542-94557678-DE73-4B2A-9679-01BC689FD665Q35123218-A927AC75-86E0-4452-AE77-D0DC4F52BCDFQ36006859-CFDFA482-1D29-442D-9BD1-320446FAB6E9Q36019860-BB147B4F-E2F4-4551-89F4-8B91E17A544AQ36131284-A4B0A1BB-AE0B-4DC0-B278-C1E08995E6BAQ36178762-8A2BB3B4-B70B-402C-BDC7-484239C1EB96Q36403490-F080C00F-2657-426A-BC3A-75B54E3A371BQ37046045-798015A4-DF84-432B-A36C-D66AB8317F53Q37177844-51E84EC1-DA94-46BE-84FA-F69E16A0472AQ37629885-A017942B-64C4-48F2-847D-5A964F94C431Q37714909-BFCC4C61-896B-4489-B27E-D7361740CEB2Q38205860-E4483F8A-CF8F-4E8B-8265-6E7189F13730Q50018140-45236DE5-6EB8-438B-8ACF-ACDC547A4355Q58577597-0C3F5DB4-C90E-4AC7-BCA9-1423CF27206EQ59072675-417E0C7E-60CA-4EA4-94AC-6F1942BFEE69
P2860
Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification of enoxacin as ...... ucture-based virtual screening
@ast
Identification of enoxacin as ...... ucture-based virtual screening
@en
type
label
Identification of enoxacin as ...... ucture-based virtual screening
@ast
Identification of enoxacin as ...... ucture-based virtual screening
@en
prefLabel
Identification of enoxacin as ...... ucture-based virtual screening
@ast
Identification of enoxacin as ...... ucture-based virtual screening
@en
P2093
P2860
P356
P1476
Identification of enoxacin as ...... ucture-based virtual screening
@en
P2093
Ana Piedrahita
Andrew T Magis
Ashley Harris
David A Ostrov
Edgardo J Toro
Edward K L Chan
Ireni N Haroun
Kristen Sajek
L Shannon Holliday
Michael I Nagib
P2860
P304
P356
10.1021/JM900277Z
P407
P577
2009-08-01T00:00:00Z